Study: dual‑target off‑the‑shelf CAR‑T cells resist rejection, curb tumor escape in mice
Nature Communications study finds donor 'off‑the‑shelf' CAR‑T cells targeting CD19 and CD70 persist longer and better control tumors in preclinical models.